Trials / Sponsors / Theriva Biologics, Inc.
Theriva Biologics, Inc.
Industry · 8 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Multiple Ascending Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Enteritis Caused by Radiation | Phase 1 | 2021-10-18 |
| Completed | Pharmacokinetics, Safety, and Tolerability of SYN-020 Enteritis Caused by Radiation (Disorder) | Phase 1 | 2021-03-22 |
| Active Not Recruiting | SYN-004 Safety and Tolerability in Allo-HCT Subjects Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant, Prevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics | Phase 1 / Phase 2 | 2021-02-15 |
| Completed | A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI Clostridium Difficile, Clostridium Infections | Phase 2 | 2015-10-01 |
| Completed | A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS Irritable Bowel Syndrome With Constipation (IBS-C) | Phase 2 | 2015-10-01 |
| Completed | A Study of the Effect of SYN-010 on Subjects With IBS-C Irritable Bowel Syndrome With Constipation (IBS-C) | Phase 2 | 2015-06-01 |
| Completed | A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an Ileostom Healthy Volunteers With Ileostomy | Phase 1 / Phase 2 | 2015-06-01 |
| Completed | A Study to Evaluate the Effect of SYN-004 on the PK of IV Ceftriaxone in Adults With a Functioning Ileostomy Healthy Volunteers | Phase 1 / Phase 2 | 2015-03-01 |